Roche Licensee Sues Parse Bio Over DNA Sequencing Products (1)

Scale Biosciences Inc. alleges that Parse Biosciences Inc.’s Evercode Whole Transcriptome line of single-cell gene expression products infringe three patents that Roche Holding AG licensed for the technology, which “allows single-cell sequencing to proceed at vastly greater scale than prior methods,” a federal lawsuit says.

The invention “eliminates the need for specialized equipment to separate cells prior to sequencing” by using the cell or nucleus “as its own reaction vessel in which to attach barcode label components to target molecules for sequencing,” according to a complaint filed Wednesday in the US District Court for the District of Delaware.

“ScaleBio’s single ...